CN1857589A - Method of measuring icariin and epimedin c content in Xianlinggubao preparation - Google Patents

Method of measuring icariin and epimedin c content in Xianlinggubao preparation Download PDF

Info

Publication number
CN1857589A
CN1857589A CN 200610200322 CN200610200322A CN1857589A CN 1857589 A CN1857589 A CN 1857589A CN 200610200322 CN200610200322 CN 200610200322 CN 200610200322 A CN200610200322 A CN 200610200322A CN 1857589 A CN1857589 A CN 1857589A
Authority
CN
China
Prior art keywords
epimedin
icariin
content
preparation
reference substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200610200322
Other languages
Chinese (zh)
Inventor
周宁
冯泽熹
谭静
杨昌生
朱颖
童寅
余励
庞媛媛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinopharm Group Tongjitang Guizhou Pharmaceutical Co Ltd
Original Assignee
Guizhou Tongjitang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guizhou Tongjitang Pharmaceutical Co Ltd filed Critical Guizhou Tongjitang Pharmaceutical Co Ltd
Priority to CN 200610200322 priority Critical patent/CN1857589A/en
Publication of CN1857589A publication Critical patent/CN1857589A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention discloses the method of measuring icariin and epimedin C content in Xianlinggubao preparation, and the method is one high efficiency liquid chromatography method with icariin and epimedin C contrast and acetonitrile/water as flowing phase. Compared with available technology, the method adopts high efficiency separating column, replacement of the flowing phase component to separate icariin and epimedin C peaks completely, content limit redetermined based on experiment, increased epimedin C content limit with relatively greater peak area, and determined ratio range between icariin and epimedin C, so as to perfect the quality detection standard of Xianlinggubao preparation and ensure the medicine safe, effective and reliable.

Description

The content assaying method of icariin and epimedin in the XIANLING GUBAO ZHIJI
Technical field: the present invention relates to the content assaying method of icariin and epimedin in a kind of XIANLING GUBAO ZHIJI, belong to drug quality control technology field.
Background technology: the contained chemical constituent of Herba Epimedii is flavonoid, lignan's class, volatile oil, ceryl alcohol, hentriacontane, plant sterol, tannin and oils etc.Herba Epimedii has kidney-replenishing, bone and muscle strengthening, and the effect of wind-damp dispelling is mainly used in impotence and seminal emission, and the muscles and bones flaccidity is soft, rheumatic arthralgia, numbness contracture, diseases such as climacteric hypertension.XIANLING GUBAO ZHIJI is combined by Herba Epimedii, Radix Dipsaci, Radix Salviae Miltiorrhizae, the Rhizoma Anemarrhenae, Fructus Psoraleae and Radix Rehmanniae, has nourishing the liver and kidney, and reunion of bone is kept fit the function of strong bone, is mainly used in osteoporosis and osteoporosis, fracture, osteoarthritis, aseptic necrosis of bone etc.In XIANLING GUBAO ZHIJI, monarch drug in the Herba Epimedii side of being plays a part crucial reinforcing the kidney and supporting YANG, strengthening the tendons and bones, therefore can effectively control the quality of XIANLING GUBAO ZHIJI to the assay of epimedium herb in the preparation, thereby guarantee its clinical efficacy.
At present, the index composition of the epimedium herb that pharmacopeia requires only is an icariin, find through experimental study: owing to be subjected to condition restriction, icariin peak and epimedin peak overlapping caused content higher in the mensuration process when former content Determination of Icariin bioassay standard was set up.And learn after deliberation: the content of epimedin is higher than other flavones ingredients far away in the effective site in the Herba Epimedii (total flavones).So necessity of the quality standard that increases epimedium herb index composition is arranged, promptly increases the assay of epimedin.
Summary of the invention:
The objective of the invention is to: the content assaying method that icariin and epimedin in a kind of XIANLING GUBAO ZHIJI are provided, the present invention on the basis of existing technology, adopt the high efficiency separation post, the mobile phase component is changed, the icariin peak is thoroughly separated with the epimedin peak, and reformulated content limit through overtesting, increased the content limit of the epimedin that wherein peak area is bigger, thereby formulated proportion between the two, made the quality inspection standard of XIANLING GUBAO ZHIJI more perfect.
XIANLING GUBAO ZHIJI of the present invention is to be prepared from by Herba Epimedii, Radix Dipsaci, Radix Salviae Miltiorrhizae, the Rhizoma Anemarrhenae, Fructus Psoraleae and the Radix Rehmanniae relevant criterion [as WS-10269 (ZD-0269)-2002, WS-10289 (ZD-0289)-2002] according to China national Drug Administration.
The content assaying method of icariin and epimedin is to be contrast with icariin and epimedin reference substance in the XIANLING GUBAO ZHIJI of the present invention, and with acetonitrile: water is the high performance liquid chromatography of mobile phase.
Specifically, the content assaying method of icariin and epimedin is in the XIANLING GUBAO ZHIJI:
According to an appendix VID of Chinese Pharmacopoeia version in 2005 high effective liquid chromatography for measuring:
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile: water=25: 75 is mobile phase; The detection wavelength is 270nm; Number of theoretical plate calculates by the epimedin peak should be lower than 5000; Number of theoretical plate calculates by the icariin peak should be lower than 5000;
It is an amount of that the preparation precision of reference substance solution takes by weighing in the phosphorus pentoxide vacuum drying apparatus dry 36 hours icariin and epimedin reference substance, add methanol and make the mixed solution that every 1ml contains icariin and epimedin 50 μ g, 25 μ g respectively, product solution in contrast, promptly;
This preparation or its content under the content uniformity item got in the preparation of need testing solution, and porphyrize is got 0.5g, the accurate title, decide, and puts in the tool plug conical flask, the accurate Diluted Alcohol 50ml that adds, claim to decide weight, supersound process is 30~60 minutes under power 250W, frequency 25kHz, puts cold, claim again to decide weight, supply the weight that subtracts mistake, shake up with Diluted Alcohol, get supernatant, filter, get subsequent filtrate, promptly;
Algoscopy is drawn reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures, promptly;
Every of this capsule contains epimedin and icariin must not be less than 1.0mg, 0.5mg respectively, and epimedin and icariin peak area ratio must not be less than 2: 1.
In order to ensure content assaying method science of the present invention, reasonable, feasible, the applicant has carried out following experimental study:
1. the selection of assay index components
Herba Epimedii is the monarch drug in the XIANLING GUBAO ZHIJI side, Herba Epimedii mainly contains flavone compound, comprise epimedin, icariin, also contain composition and lignin compositions such as icariin-I, icariin-C, hyperin, precious icariin-I, rhamanopyranosyl icariside-II, arrow icariin B, precious icariin-II, Flos Caryophylli icariin C and Flos Caryophylli icariin F.Has kidney-replenishing, bone and muscle strengthening, the effect of wind-damp dispelling.Modern pharmacology studies show that Herba Epimedii has the raising sexual function, enhancing immunity, and the protection heart improves myocardial ischemia, increases coronary flow, anti-arrhythmia, blood pressure lowering, antiplatelet aggregation, antiinflammatory, the anti-ageing effect of waiting for a long time.Through correlational study as can be known: the content of epimedin is higher than other flavones ingredients far away in the effective site in the Herba Epimedii (total flavones), therefore, is necessary to increase the assay of epimedin, further to improve the quality standard of Herba Epimedii index composition.
In order to finish the present invention, the applicant investigates the epimedium herb extraction process, determine optimum extraction process, and prepare a large amount of epimedins, the total flavones process of enriching is investigated, use macroporous resin and carry out epimedin and separate, purification, and formulated that specificity is strong, highly sensitive, the high performance liquid chromatography of stability and favorable reproducibility, reliable results.
2. instrument and reagent
Instrument: high performance liquid chromatograph Agilent1100, DAD detector, Agilent work station.
Chromatographic column: Agilent ODS 5 μ m 4.0 * 250mm
Reference substance: icariin, epimedin.
Reagent: acetonitrile (chromatographically pure, Fisher), WAHAHA pure water (Hangzhou Wahaha Group Co.,Ltd), ethanol (analytical pure, Beijing Chemical Plant).
3. method and result
3.1 chromatographiccondition
Mobile phase: acetonitrile-water (25: 75); Flow velocity: 1ml/min; Detect wavelength: 270nm; Number of theoretical plate calculates by epimedin and is not less than 5000.
3.2 selection of experiment conditions
3.2.1 measure the selection of wavelength:
With dissolve with methanol epimedin reference substance, make the solution that every 1ml contains 0.05mg, the U-2000 type visible-measure absorption spectrum on the uv-spectrophotometric instrument, the result has absorption maximum at 270nm place, so selection 270nm is as the detection wavelength.
3.2.2 the selection of mobile phase:
Acetonitrile-water (30: 70) on probation, the peak type is bad, and separating effect is very undesirable.
Change acetonitrile-water (24: 76) into, reach preferably and separate.
3.2.3 blank assay
The preparation of blank solution is the ratio in the prescription taste of Chinese medicine, autogamy does not contain group's medicine of Herba Epimedii, make blank preparation by its technology, press need testing solution preparation method preparation again and measure, blank solution is not being seen chromatographic peak with epimedin, retention time place that the icariin reference substance is identical as a result.
3.2.4 extracting solvent selects:
Take by weighing XIANLING GUBAO ZHIJI 0.5g (lot number 051209), the accurate title, decide, and puts in the tool plug conical flask, adds methanol, Diluted Alcohol, each 50ml of ethanol respectively, and supersound process 1 hour is measured its icariin and epimedin content.The results are shown in Table 1:
The different influences of extracting solvent of table 1 to epimedin, icariin content
Extract solvent Methanol Diluted Alcohol Ethanol
Epimedin content (mg/g) icariin content (mg/g) 3.2642 1.5642 4.0537 1.7577 3.7135 1.4128
The result shows that the effect of Diluted Alcohol do extraction solvent is best.Therefore, select for use Diluted Alcohol to extract as extracting solvent.
3.2.5 extraction time is determined:
Take by weighing XIANLING GUBAO ZHIJI 0.5g (lot number 051209), the accurate title, decide, and puts in the tool plug conical flask, add Diluted Alcohol 50ml respectively, supersound process (power 250W, frequency 25KHz) each 0.5,1.0,1.5 hour, measure the content of its icariin and epimedin, the results are shown in Table 2:
Table 2 different extraction times are to the influence of epimedin, icariin content
Extraction time (min) 0.5 1.0 1.5
Epimedin content (mg/g) icariin content (mg/g) 3.1243 1.6507 4.1584 1.7385 4.2069 1.7315
According to above result, select supersound extraction 1 hour comparatively suitable.
3.3 linear relationship is investigated
Accurate epimedin reference substance solution (0.0404mg/ml) 2,4,8,12, the 16 μ l that draw, inject chromatograph of liquid, the record peak area, (μ g) is abscissa with reference substance epimedin sample size, is vertical coordinate with the peak area, the drawing standard curve, its regression equation is A=1509.3524X+13.7157 (r=0.9992), brings the disconnected minimum point value of linearity into following formula and calculates, and relative deviation is less than 1% as a result, think that working curve was similar to initial point, therefore adopt the appearance one point method to calculate.The result shows that the epimedin sample size is the good linear relation in 0.0808~0.6464 μ g scope.
In like manner, accurate icariin reference substance solution (0.1004mg/ml) 1,3,5,8, the 10 μ l that draw, inject chromatograph of liquid, the record peak area, (μ g) is abscissa with reference substance icariin sample size, with the peak area is vertical coordinate, the drawing standard curve, its regression equation is Y=2109.8x+4.6272 (r=0.9998), fitting to former point equation is: Y=2115.063X, and bring the short minimum point value of linearity into above-mentioned two formulas and calculate, relative deviation is 0.96% as a result, think that working curve was similar to initial point, therefore adopt one point external standard method to calculate.The result shows that the icariin sample size is the good linear relation in 0.10~1.2 μ g scope.The results are shown in Table 3, table 4.
Table 3 epimedin linear relationship is investigated
Sampling volume (μ l) 2 4 8 12 16
Sample size (μ g) 0.0808 0.1616 0.3232 0.4848 0.6464
Peak area (Mau*s) 125.24849 257.19345 511.98727 762.33679 972.88281
Table 4 icariin linear relationship is investigated
The amount of icariin (μ g) 0.1004 0.3012 0.5020 0.8032 1.004 1.2048
Peak area (Mau*s) 200.660 639.502 1076.194 1727.701 2112.015 2532.912
3.4 stability test
Get same test sample (lot number 051214) 0.5g, the need testing solution preparation method is prepared in the reference standard, respectively at preparation back 0,2,4,6,8,10 hours, measure epimedin and icariin peak area according to last method, the record peak area value, the result shows that need testing solution is good at 10 hours internal stabilities, sees Table 5,6.
Table 5 epimedin stability experiment
Time Peak area (Mau*s) Average RSD(%)
0 725.74371 712.788 1.131
2 719.83386
4 705.53790
6 707.99670
8 708.32776
10 709.28516
Table 6 icariin stability experiment
Time Peak area (Mau*s) Average RSD(%)
0 1012.313 1025.003 1.29%
2 1022.716
4 1020.080
6 1047.485
8 1022.419
3.5 precision test
Accurate same epimedin (C=0.0404mg/ml), each 10 μ l of icariin (C=0.1004mg/ml) reference substance solution of drawing repeat sample introduction 6 times, measure peak area and write down collection of illustrative plates, the results are shown in Table 7,8.The result shows that precision meets the requirements.
The test of table 7 epimedin precision
Peak area (Mau*s) Average RSD(%)
1 639.66168 641.371 0.188
2 641.82422
3 641.55096
4 640.18201
5 642.76141
6 642.24707
The test of table 8 icariin precision
Peak area (Mau*s) Average RSD(%)
1 2161.172
2 2118.171
3 2166.837 2133.01 1.36
4 2115.738
5 2103.102
3.6 replica test
Same lot number (051214) sample is taken by weighing 5 parts, prepare test liquid, measure its epimedin and icariin content in accordance with the law, the results are shown in Table 9,10 by the method under the assay item of the present invention.Experimental result shows that this method repeatability is good.
Epimedin measurement result in table 9 replica test
Sample size (g) Chao Huoding C content (mg/g) Average content (mg/g) RSD(%)
1 0.5042 4.4074 4.4561 1.78
2 0.5025 4.4805
3 0.5023 4.5336
4 0.5128 4.3439
5 0.5007 4.5151
Icariin measurement result in table 10 replica test
Sample size (g) Icariin content (mg/g) Average content (mg/g) RSD(%)
1 0.5042 1.9856 1.9909 0.79
2 0.5025 1.9892
3 0.5023 1.9692
4 0.5128 2.0115
5 0.5007 1.9988
3.7 recovery test
Adopt the application of sample absorption method.Precision takes by weighing the same lot number (lot number 051214 of known content, known epimedin and icariin content are respectively 4.4561mg/g, 1.9909mg/g) the about 0.25g of sample each 5 parts, the accurate title, decide, accurate respectively adding epimedin and icariin mix each 50ml of reference substance solution and (get epimedin, icariin reference substance, add Diluted Alcohol and make the solution that concentration is respectively 0.024mg/ml, 7.52 μ g/ml), preparation method preparation and above-mentioned chromatographic condition by test liquid under the assay item of the present invention are measured calculate recovery rate.The results are shown in Table 11,12.
Epimedin recovery test and result in the celestial Ling Neibao capsule of table 11
Sequence number Sample sample weighting amount (g) Sample epimedin amount (mg) Add epimedin amount (mg) The epimedin amount of recording (mg) The response rate (%) Average recovery rate (%) RSD (%)
1 0.2505 1.1163 1.20 2.3135 99.77 100.11 1.99
2 0.2486 1.1078 1.20 2.3340 102.18
3 0.2517 1.1216 1.20 2.3442 101.88
4 0.2609 1.1630 1.20 2.3308 97.32
5 0.2526 1.1256 1.20 2.3182 99.38
Icariin recovery test and result in the celestial Ling Neibao capsule of table 12
Sequence number Sample sample weighting amount (g) The icariin amount of recording (mg) Sample icariin amount (mg) Add icariin amount (mg) The response rate (%) Average recovery rate (%) RSD (%)
1 0.2505 0.8755 0.4987 0.376 100.21 97.47 2.19
2 0.2486 0.8591 0.4949 96.86
3 0.2517 0.8608 0.5011 95.66
4 0.2609 0.8923 0.5194 99.18
5 0.2526 0.8617 0.5029 95.42
Above result shows that epimedin and icariin average recovery rate are respectively 100.11%, 97.47%, and RSD is respectively 1.99%, 2.19%.Illustrate that this method is feasible.
According to above result of the test, the condition of content assaying method of the present invention is defined as: with octadecylsilane chemically bonded silica is filler; Acetonitrile-water (25: 75) is a mobile phase; Flow velocity: 1.0ml/min; The detection wavelength is 270nm.Number of theoretical plate calculates by the epimedin peak should be not less than 5000.
Need testing solution preparation method of the present invention is defined as: get this preparation or its content under the content uniformity item, porphyrize is got 0.5g, the accurate title, decide, and puts in the tool plug conical flask, the accurate Diluted Alcohol 50ml that adds, claim to decide weight, supersound process (power 250W, frequency 25kHz) 1 hour, put cold, claim again to decide weight, supply the weight that subtracts mistake, shake up with ethanol, filter, promptly.
3.8 this algoscopy of assay computational methods adopts one point external standard method to calculate content, precision takes by weighing test sample 0.5g, prepares test liquid by quality standard, and sample introduction is measured, and computing formula is as follows.
(1) need testing solution concentration is calculated:
C S = C R × A S A R - - - ( 1 )
In the formula: C S: be need testing solution concentration (mg/ml).
C R: be reference substance solution concentration (mg/ml).
A s: be need testing solution peak area value (mAu*s)
A R: be reference substance solution peak area value (mAu*s)
(2) formulation content computing formula:
Figure A20061020032200092
In the formula: C s: need testing solution concentration (mg/ml)
V S: be the volume (ml) of need testing solution.
W 1: be the weighing (g) of sample.
W 2: be average particle heavy (g).
Merge (1) (2) formula, its computing formula is (3):
3.9 sample determination and content limit are formulated us to ten batches of our company " XIANLING GUBAO JIAONANG ", by its epimedin of above-mentioned high effective liquid chromatography for measuring and icariin content, the results are shown in Table 13.
Table 13 epimedin measurement result table
Lot number Epimedin average peak area (Mau*s) (n=2) Chao Huoding C average content (mg/ grain) (n=2) Icariin average peak area (Mau*s) (n=2) Icariin average content (mg/ grain) (n=2)
040905 041001 041010 041013 050718 051204 051207 051208 051210 051212 469.256 473.598 0.958 0.979 244.278 248.595 0.486 0.477
546.859 551.105 1.561 1.529 319.742 308.815 0.569 0.575
915.716 922.924 2.407 2.384 419.598 403.426 0.671 0.658
745.802 740.298 1.655 1.591 268.069 257.332 0.516 0.528
I380.982 1389.703 2.964 2.896 347.301 354.459 0.612 0.606
941.804 940.704 2.451 2.440 334.781 337.916 0.715 0.728
983.635 992.806 2.615 2.528 297.723 290.498 0.551 0.548
834.491 849.264 1.726 1.735 479.682 469.251 0.865 0.837
1024.562 1025.796 2.685 2.706 311.879 309.765 0.914 0.925
974.672 949.236 2.562 2.511 318.255 313.206 0.584 0.576
According to above epimedin and ten batches of peak areas of icariin and assay result, every contains epimedin and icariin must not be less than 1.0mg, 0.5mg respectively in tentative " XIANLING GUBAO JIAONANG ", and epimedin and icariin peak area ratio must not be less than 2: 1.
Compared with prior art, content assaying method of the present invention adopts the high efficiency separation post, the mobile phase component is changed, the icariin peak is thoroughly separated with the epimedin peak, and reformulated content limit through overtesting, increase the content limit of the epimedin that wherein peak area is bigger, thereby formulated proportion between the two, make the quality inspection standard of XIANLING GUBAO ZHIJI more perfect, thereby guaranteed safety, effectiveness, the reliability of medicine.
The specific embodiment:
Embodiments of the invention 1: the content assaying method of icariin and epimedin is in the XIANLING GUBAO ZHIJI:
According to an appendix VID of Chinese Pharmacopoeia version in 2005 high effective liquid chromatography for measuring:
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile: water=25: 75 is mobile phase; The detection wavelength is 270nm; Number of theoretical plate calculates by the epimedin peak should be lower than 5000;
It is an amount of that the preparation precision of reference substance solution takes by weighing in the phosphorus pentoxide vacuum drying apparatus dry 36 hours icariin and epimedin reference substance, add methanol and make the mixed solution that every 1ml contains icariin and epimedin 50 μ g, 25 μ g respectively, product solution in contrast, promptly;
This preparation or its content under the content uniformity item got in the preparation of need testing solution, and porphyrize is got 0.5g, the accurate title, decide, and puts in the tool plug conical flask, the accurate Diluted Alcohol 50ml that adds, claim to decide weight, supersound process is 60 minutes under power 250W, frequency 25kHz, puts cold, claim again to decide weight, supply the weight that subtracts mistake, shake up with ethanol, get supernatant, filter, get subsequent filtrate, promptly;
Algoscopy is drawn reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures, promptly;
Every of this capsule contains epimedin and icariin must not be less than 1.0mg, 0.5mg respectively, and epimedin and icariin peak area ratio must not be less than 2: 1.

Claims (2)

1. the content assaying method of icariin and epimedin in the XIANLING GUBAO ZHIJI is characterized in that: it is to be contrast with icariin and epimedin reference substance, and with acetonitrile: water is the high performance liquid chromatography of mobile phase.
2. according to the content assaying method of icariin and epimedin in the described XIANLING GUBAO ZHIJI of claim 1, it is characterized in that: concrete assay method is:
According to an appendix VID of Chinese Pharmacopoeia version in 2005 high effective liquid chromatography for measuring:
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile: water=25: 75 is mobile phase; The detection wavelength is 270nm; Number of theoretical plate calculates by the epimedin peak should be lower than 5000; Number of theoretical plate calculates by the icariin peak should be lower than 5000;
It is an amount of that the preparation precision of reference substance solution takes by weighing in the phosphorus pentoxide vacuum drying apparatus dry 36 hours icariin and epimedin reference substance, add methanol and make the mixed solution that every 1ml contains icariin and epimedin 50 μ g, 25 μ g respectively, product solution in contrast, promptly;
This preparation or its content under the content uniformity item got in the preparation of need testing solution, and porphyrize is got 0.5g, the accurate title, decide, and puts in the tool plug conical flask, the accurate Diluted Alcohol 50ml that adds, claim to decide weight, supersound process is 30~60 minutes under power 250W, frequency 25kHz, puts cold, claim again to decide weight, supply the weight that subtracts mistake, shake up with Diluted Alcohol, get supernatant, filter, get subsequent filtrate, promptly;
Algoscopy is drawn reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures, promptly;
Every of this capsule contains epimedin and icariin must not be less than 1.0mg, 0.5mg respectively, and epimedin and icariin peak area ratio must not be less than 2: 1.
CN 200610200322 2006-04-06 2006-04-06 Method of measuring icariin and epimedin c content in Xianlinggubao preparation Pending CN1857589A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200610200322 CN1857589A (en) 2006-04-06 2006-04-06 Method of measuring icariin and epimedin c content in Xianlinggubao preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200610200322 CN1857589A (en) 2006-04-06 2006-04-06 Method of measuring icariin and epimedin c content in Xianlinggubao preparation

Publications (1)

Publication Number Publication Date
CN1857589A true CN1857589A (en) 2006-11-08

Family

ID=37296577

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200610200322 Pending CN1857589A (en) 2006-04-06 2006-04-06 Method of measuring icariin and epimedin c content in Xianlinggubao preparation

Country Status (1)

Country Link
CN (1) CN1857589A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102391335A (en) * 2011-07-29 2012-03-28 贵州同济堂制药有限公司 Isopentene flavonol glycoside derivative and preparation method and application thereof
CN102768248A (en) * 2012-05-29 2012-11-07 贵州富华药业有限责任公司 Method for determining Epimedin C and icariin content of Gusongbao preparation
CN103698454A (en) * 2013-12-17 2014-04-02 广西中烟工业有限责任公司 Detection method for measuring effective constituents of epimedium in cigarette tobacco shreds and main stream smoke of cigarettes
CN104711301A (en) * 2015-03-24 2015-06-17 北京盛诺基医药科技有限公司 Icaritin preparation method
CN105535154A (en) * 2015-12-24 2016-05-04 河南大学 Filamental flowering crab extract, active compound, preparing method and application
CN109187810A (en) * 2018-10-29 2019-01-11 广州白云山陈李济药厂有限公司 A kind of detection method for treating rheumatoid arthritis Chinese medicine composition
CN110672747A (en) * 2019-10-23 2020-01-10 劲牌生物医药有限公司 Method for detecting epimedium component, method for identifying variety of epimedium and application
CN110794059A (en) * 2019-11-13 2020-02-14 亚宝药业四川制药有限公司 Detection method of yang strengthening tablet
CN112816603A (en) * 2021-01-05 2021-05-18 天津中医药大学 Bone-strengthening joint pill fingerprint spectrum and method for detecting 18 components in bone-strengthening joint pill fingerprint spectrum

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102391335A (en) * 2011-07-29 2012-03-28 贵州同济堂制药有限公司 Isopentene flavonol glycoside derivative and preparation method and application thereof
CN102391335B (en) * 2011-07-29 2014-02-19 贵州同济堂制药有限公司 Isopentene flavonol glycoside derivative and preparation method and application thereof
CN102768248A (en) * 2012-05-29 2012-11-07 贵州富华药业有限责任公司 Method for determining Epimedin C and icariin content of Gusongbao preparation
CN103698454A (en) * 2013-12-17 2014-04-02 广西中烟工业有限责任公司 Detection method for measuring effective constituents of epimedium in cigarette tobacco shreds and main stream smoke of cigarettes
CN104711301A (en) * 2015-03-24 2015-06-17 北京盛诺基医药科技有限公司 Icaritin preparation method
CN105535154A (en) * 2015-12-24 2016-05-04 河南大学 Filamental flowering crab extract, active compound, preparing method and application
CN105535154B (en) * 2015-12-24 2019-08-06 河南大学 Hall crabapple flower extract and reactive compound, preparation method and application
CN109187810A (en) * 2018-10-29 2019-01-11 广州白云山陈李济药厂有限公司 A kind of detection method for treating rheumatoid arthritis Chinese medicine composition
CN109187810B (en) * 2018-10-29 2021-06-08 广州白云山陈李济药厂有限公司 Detection method of traditional Chinese medicine composition for treating rheumatoid arthritis
CN110672747A (en) * 2019-10-23 2020-01-10 劲牌生物医药有限公司 Method for detecting epimedium component, method for identifying variety of epimedium and application
CN110794059A (en) * 2019-11-13 2020-02-14 亚宝药业四川制药有限公司 Detection method of yang strengthening tablet
CN112816603A (en) * 2021-01-05 2021-05-18 天津中医药大学 Bone-strengthening joint pill fingerprint spectrum and method for detecting 18 components in bone-strengthening joint pill fingerprint spectrum

Similar Documents

Publication Publication Date Title
CN1857589A (en) Method of measuring icariin and epimedin c content in Xianlinggubao preparation
CN100335897C (en) Quality detection method for compound prepn of red sage and notoginseng
CN1895408A (en) Radix saposhnikoviae Tong Sheng capsules, preparation and quality control thereof
CN1141575C (en) Red sage medicine fingerprint establishing method and standard fingerprint atlas
CN101049389A (en) Method for controlling quality of granule preparation for treating chilly sensation type gastritis
CN106370738B (en) Fingerprint quality determination method for periplaneta americana medicinal material
CN101028388A (en) Quality inspection of Chinese-medicinal preparation for treating shortsighness and asthenopia
CN104897787A (en) Method for simultaneous determination of six active components in Niuhuang Ninggong tablet
CN102426205B (en) Detection method of thrombus sumalin capsules
CN101028460A (en) Method for inspecting throat-clearing Chinese medicinal pills
CN101029889A (en) Method for inspecting Chinese medicinal preparation quality in treatment of old man eyes dieases
CN104569195B (en) A kind of method of flavonoids effective constituent content in toothpaste detected containing baikal skullcap root
CN1932506A (en) Method for establishing evodia rutaecarpa liposoluble fingerprint and standard fingerprint thereof
CN101028487A (en) Chinese-medicinal preparation for treating eyeground bleeding and method for inspecting vision-improving prescription quality
CN101040951A (en) Method of controlling the quality of Ynxingchao dropping pills compound
CN1844912A (en) Earthworm fingerprint spectrum establishment method and medicinal earthworm identification method
CN1932507A (en) Method for establishing evodia rutaecarpa water-soluble fingerprint and standard fingerprint thereof
CN1907340A (en) Quality checking and controlling method for renal stone removal preparation
CN1844911A (en) Leech fingerprint spectrum establishment method and medicinal leech identification method
CN1679811A (en) Danshen root extract, production, medicine preparation and inspection thereof
CN1314789C (en) Method for preparing pure oleum fructus brucease
CN111929378B (en) Method for measuring content of 6 index components of gastrodia elata in Qingda granules
CN107582639A (en) A kind of vinegar corydalis tuber granule and preparation method thereof
CN101029890A (en) Method for inspecting Chinese-medicinal preparation Kaiyinwan
CN1840032A (en) Granule for treating infant's rhinitis, its preparation method and quality control method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20061108